Literature DB >> 24627491

Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition.

Natasha Kolesnikoff1, Joanne L Attema, Suraya Roslan, Andrew G Bert, Quenten P Schwarz, Philip A Gregory, Gregory J Goodall.   

Abstract

Epithelial-mesenchymal transition (EMT) is required for the specification of tissues during embryonic development and is recapitulated during the metastatic progression of tumors. The miR-200 family plays a critical role in enforcing the epithelial state with their expression lost in cells undergoing EMT. EMT can be mediated by activation of the ZEB1 and ZEB2 (ZEB) transcription factors, which repress miR-200 expression via a self-reinforcing double negative feedback loop to promote the mesenchymal state. However, it remains unclear what factors drive and maintain epithelial-specific expression of miR-200 in the absence of EMT-inducing factors. Here, we show that the transcription factor Specificity Protein 1 (Sp1) binds to the miR-200b∼200a∼429 proximal promoter and activates miR-200 expression in epithelial cells. In mesenchymal cells, Sp1 expression is maintained, but its ability to activate the miR-200 promoter is perturbed by ZEB-mediated repression. Reduction of Sp1 expression caused changes in EMT-associated markers in epithelial cells. Furthermore, we observed co-expression of Sp1 and miR-200 during mouse embryonic development wherein miR-200 expression was only lost in regions with high ZEB expression. Together, these findings indicate that miR-200 family members require Sp1 to drive basal expression and to maintain an epithelial state.

Entities:  

Keywords:  Epithelial mesenchymal transition; Metastasis; MicroRNA; Sp1; Transcription; ZEB transcription factor; miR-200

Mesh:

Substances:

Year:  2014        PMID: 24627491      PMCID: PMC4036258          DOI: 10.1074/jbc.M113.529172

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.

Authors:  Jason I Herschkowitz; Wei Zhao; Mei Zhang; Jerry Usary; George Murrow; David Edwards; Jana Knezevic; Stephanie B Greene; David Darr; Melissa A Troester; Susan G Hilsenbeck; Daniel Medina; Charles M Perou; Jeffrey M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-01       Impact factor: 11.205

Review 2.  To differentiate or not--routes towards metastasis.

Authors:  Thomas Brabletz
Journal:  Nat Rev Cancer       Date:  2012-05-11       Impact factor: 60.716

3.  Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

Authors:  Jeff H Tsai; Joana Liu Donaher; Danielle A Murphy; Sandra Chau; Jing Yang
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

4.  miR-200b regulates cell migration via Zeb family during mouse palate development.

Authors:  Jeong-Oh Shin; Eizo Nakagawa; Eun-Jung Kim; Kyoung-Won Cho; Jong-Min Lee; Sung-Won Cho; Han-Sung Jung
Journal:  Histochem Cell Biol       Date:  2012-01-20       Impact factor: 4.304

5.  Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer.

Authors:  E J H Wee; K Peters; S S Nair; T Hulf; S Stein; S Wagner; P Bailey; S Y Lee; W J Qu; B Brewster; J D French; A Dobrovic; G D Francis; S J Clark; M A Brown
Journal:  Oncogene       Date:  2012-01-09       Impact factor: 9.867

6.  Sp1 expression regulates lung tumor progression.

Authors:  T-I Hsu; M-C Wang; S-Y Chen; Y-M Yeh; W-C Su; W-C Chang; J-J Hung
Journal:  Oncogene       Date:  2011-12-12       Impact factor: 9.867

7.  Cell type-specific transcriptome analysis reveals a major role for Zeb1 and miR-200b in mouse inner ear morphogenesis.

Authors:  Ronna Hertzano; Ran Elkon; Kiyoto Kurima; Annie Morrisson; Siaw-Lin Chan; Michelle Sallin; Andrew Biedlingmaier; Douglas S Darling; Andrew J Griffith; David J Eisenman; Scott E Strome
Journal:  PLoS Genet       Date:  2011-09-29       Impact factor: 5.917

8.  Transcriptional networks in epithelial-mesenchymal transition.

Authors:  Christo Venkov; David Plieth; Terri Ni; Amitava Karmaker; Aihua Bian; Alfred L George; Eric G Neilson
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

9.  An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription.

Authors:  Emily C Knouf; Kavita Garg; Jason D Arroyo; Yesenia Correa; Deepayan Sarkar; Rachael K Parkin; Kaitlyn Wurz; Kathy C O'Briant; Andrew K Godwin; Nicole D Urban; Walter L Ruzzo; Robert Gentleman; Charles W Drescher; Elizabeth M Swisher; Muneesh Tewari
Journal:  Nucleic Acids Res       Date:  2011-09-14       Impact factor: 16.971

10.  Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis.

Authors:  V Davalos; C Moutinho; A Villanueva; R Boque; P Silva; F Carneiro; M Esteller
Journal:  Oncogene       Date:  2011-08-29       Impact factor: 9.867

View more
  28 in total

1.  A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.

Authors:  L A Selth; R Das; S L Townley; I Coutinho; A R Hanson; M M Centenera; N Stylianou; K Sweeney; C Soekmadji; L Jovanovic; C C Nelson; A Zoubeidi; L M Butler; G J Goodall; B G Hollier; P A Gregory; W D Tilley
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

2.  Transcription Factor Hepatocyte Nuclear Factor-1β (HNF-1β) Regulates MicroRNA-200 Expression through a Long Noncoding RNA.

Authors:  Sachin S Hajarnis; Vishal Patel; Karam Aboudehen; Massimo Attanasio; Patricia Cobo-Stark; Marco Pontoglio; Peter Igarashi
Journal:  J Biol Chem       Date:  2015-08-19       Impact factor: 5.157

3.  Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma.

Authors:  Lindsay M LaFave; Vinay K Kartha; Sai Ma; Kevin Meli; Isabella Del Priore; Caleb Lareau; Santiago Naranjo; Peter M K Westcott; Fabiana M Duarte; Venkat Sankar; Zachary Chiang; Alison Brack; Travis Law; Haley Hauck; Annalisa Okimoto; Aviv Regev; Jason D Buenrostro; Tyler Jacks
Journal:  Cancer Cell       Date:  2020-07-23       Impact factor: 31.743

4.  DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells.

Authors:  Hong-Pan Tian; Shu-Min Lun; Huan-Jing Huang; Rui He; Peng-Zhou Kong; Qing-Shan Wang; Xiao-Qing Li; Yu-Mei Feng
Journal:  J Biol Chem       Date:  2015-06-12       Impact factor: 5.157

5.  Suppression of MicroRNA 200 Family Expression by Oncogenic KRAS Activation Promotes Cell Survival and Epithelial-Mesenchymal Transition in KRAS-Driven Cancer.

Authors:  Xiaomin Zhong; Lan Zheng; Jianfeng Shen; Dongmei Zhang; Minmin Xiong; Youyou Zhang; Xinhong He; Janos L Tanyi; Feng Yang; Kathleen T Montone; Xiaojun Chen; Congjian Xu; Andy P Xiang; Qihong Huang; Xiaowei Xu; Lin Zhang
Journal:  Mol Cell Biol       Date:  2016-10-13       Impact factor: 4.272

6.  Cutaneous Epithelial to Mesenchymal Transition Activator ZEB1 Regulates Wound Angiogenesis and Closure in a Glycemic Status-Dependent Manner.

Authors:  Kanhaiya Singh; Mithun Sinha; Durba Pal; Saba Tabasum; Surya C Gnyawali; Dolly Khona; Subendu Sarkar; Sujit K Mohanty; Fidel Soto-Gonzalez; Savita Khanna; Sashwati Roy; Chandan K Sen
Journal:  Diabetes       Date:  2019-08-22       Impact factor: 9.461

7.  MicroRNA-Specificity Protein (Sp) Transcription Factor Interactions and Significance in Carcinogenesis.

Authors:  Stephen Safe
Journal:  Curr Pharmacol Rep       Date:  2015-01-11

8.  Transcriptional repression of E-cadherin in nickel-exposed lung epithelial cells mediated by loss of Sp1 binding at the promoter.

Authors:  Xiaoru Zhang; Vinay Singh Tanwar; Cynthia C Jose; Hyun-Wook Lee; Suresh Cuddapah
Journal:  Mol Carcinog       Date:  2021-11-02       Impact factor: 4.784

9.  MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.

Authors:  YaSai Yao; Jian Hu; Zan Shen; RuYong Yao; ShiHai Liu; Yong Li; Hui Cong; XinGang Wang; WenSheng Qiu; Lu Yue
Journal:  J Cell Mol Med       Date:  2015-01-30       Impact factor: 5.310

Review 10.  The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.

Authors:  Brock Humphries; Chengfeng Yang
Journal:  Oncotarget       Date:  2015-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.